MannKind Corporation (MNKD) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
MannKind Corporation (MNKD) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$142.90 MLiabilities$799.50 MNon-current liabilities$656.60 MCurrent assets$245.71 MAssets$732.30 MNon-current assets$486.59 MEquity−$67.20 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSShort-term investmentsCash and cash equivalentsPrepaid expenses and other current assetsInventoryAccounts receivable, netDeveloped technology - on-body infusorIPR&D - ReadyFlow FormulationProperty and equipment, netGoodwillOther assetsOther intangible assetsRestricted cashAccrued expenses and other current liabilitiesContingent consideration - currentLiability for sale of future royalties - currentDeferred revenue — currentAccounts payableFinancing liability - currentRecognized loss on purchase commitments - currentTerm loanLiability for sale of future royalties - long termFinancing liability - long termRecognized loss on purchase commitments — long termDeferred revenue — long termOperating lease liabilityMilestone liabilitiesAdditional paid-in capitalCommon stock, $0.01 par value - 800,000,000 shares authorized; 309,911,682 and 307,832,587 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectivelyAccumulated deficitAccumulated other comprehensive (loss) incomeCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$60.77 MContingent consideration - currentContingent consideration - current$34.02 MCurrent liabilitiesCurrent liabilities$142.90 MLiability for sale of future royalties - currentLiability for sale of future royalties - current$14.29 MDeferred revenue — currentDeferred revenue — current$11.09 MAccounts payableAccounts payable$11.04 MLiabilitiesLiabilities$799.50 MFinancing liability - currentFinancing liability - current$10.49 MRecognized loss on purchase commitments - currentRecognized loss on purchase commitments - current$1.21 MNon-current liabilitiesNon-current liabilities$656.60 MTerm loanTerm loan$319.09 MLiability for sale of future royalties - long termLiability for sale of future royalties - long term$133.55 MFinancing liability - long termFinancing liability - long term$92.50 MRecognized loss on purchase commitments — long termRecognized loss on purchase commitments — long term$62.92 MDeferred revenue — long termDeferred revenue — long term$36.86 MOperating lease liabilityOperating lease liability$9.69 MMilestone liabilitiesMilestone liabilities$2.00 MAdditional paid-in capitalAdditional paid-in capital$3.16 BShort-term investmentsShort-term investments$58.20 MCurrent assetsCurrent assets$245.71 MCash and cash equivalentsCash and cash equivalents$52.93 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$46.96 MAssetsAssets$732.30 MInventoryInventory$44.42 MAccounts receivable, netAccounts receivable, net$43.21 MDeveloped technology - on-body infusorDeveloped technology - on-body infusor$181.39 MNon-current assetsNon-current assets$486.59 MIPR&D - ReadyFlow FormulationIPR&D - ReadyFlow Formulation$129.60 MProperty and equipment, netProperty and equipment, net$85.16 MGoodwillGoodwill$67.60 MOther assetsOther assets$17.12 MOther intangible assetsOther intangible assets$4.98 MRestricted cashRestricted cash$749.00 KEquityEquity−$67.20 MCommon stock, $0.01 par value - 800,000,000 shares authorized; 309,911,682 and 307,832,587 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectivelyCommon stock$3.10 MAccumulated deficitAccumulated deficit−$3.23 BAccumulated other comprehensive (loss) incomeAccumulated other comprehensive (loss) income−$19.00 K
Chart details

MannKind Corporation (MNKD) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
732,304,000 US dollars
Current assets
245,712,000 US dollars
Non-current assets
486,592,000 US dollars
Liabilities
799,501,000 US dollars
Current liabilities
142,898,000 US dollars
Non-current liabilities
656,603,000 US dollars
Equity
negative 67,197,000 US dollars
Short-term investments
58,201,000 US dollars
Cash and cash equivalents
52,929,000 US dollars
Prepaid expenses and other current assets
46,956,000 US dollars
Inventory
44,419,000 US dollars
Accounts receivable, net
43,207,000 US dollars
Developed technology - on-body infusor
181,389,000 US dollars
IPR&D - ReadyFlow Formulation
129,600,000 US dollars
Property and equipment, net
85,160,000 US dollars
Goodwill
67,595,000 US dollars
Other assets
17,123,000 US dollars
Other intangible assets
4,976,000 US dollars
Restricted cash
749,000 US dollars
Accrued expenses and other current liabilities
60,768,000 US dollars
Contingent consideration - current
34,015,000 US dollars
Liability for sale of future royalties - current
14,292,000 US dollars
Deferred revenue — current
11,085,000 US dollars
Accounts payable
11,042,000 US dollars
Financing liability - current
10,486,000 US dollars
Recognized loss on purchase commitments - current
1,210,000 US dollars
Term loan
319,085,000 US dollars
Liability for sale of future royalties - long term
133,552,000 US dollars
Financing liability - long term
92,497,000 US dollars
Recognized loss on purchase commitments — long term
62,922,000 US dollars
Deferred revenue — long term
36,857,000 US dollars
Operating lease liability
9,687,000 US dollars
Milestone liabilities
2,003,000 US dollars
Additional paid-in capital
3,161,330,000 US dollars
Common stock, $0.01 par value - 800,000,000 shares authorized; 309,911,682 and 307,832,587 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
3,099,000 US dollars
Accumulated deficit
negative 3,231,607,000 US dollars
Accumulated other comprehensive (loss) income
negative 19,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
MannKind Corporation (MNKD) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!